'Bot MD' is a Singapore-based health tech startup with a proprietary platform powered by artificial intelligence (AI). This platform is being developed through a collaboration with the National University Cancer Institute (NCIS) in Singapore in order to offer patients a more comprehensive cost estimate prior to receiving care. The two entities have named the cost estimator the 'NCIS Chemotherapy Cost Calculator,' and it factors in multiple variables such as residence cost, projected recovery speed, and more.
The benefits of estimating upfront cost also help in creating payment plans for patients. If an individual is in need of chemotherapy or cancer-related care and cannot afford the initial cost, the NCIS Chemotherapy Cost Calculator can provide set projections, which can lead to hospitals then working with patients on a payment plan that works for each patient.
Image Credit: Shutterstock
What Makes This Trend Stand Out
- AI-powered Cancer Treatment Cost Estimation
- Cancer treatment centers and insurance providers can adopt AI-powered cost estimation services to improve transparency and enhance patient satisfaction.
- Advanced Healthcare Technology Collaborations
- Health tech startups can form partnerships with cancer treatment centers and research institutes to develop innovative healthcare technologies.
- Patient-centric Healthcare
- Healthcare providers can prioritize patient needs by utilizing cost estimation tools that allow patients to make informed decisions about their treatment plans.
Sectors Adopting This
- Healthcare
- Healthcare providers can utilize AI-powered tools to enhance patient care, creating a more patient-centric experience.
- Insurance
- Insurance providers can collaborate with healthcare providers to offer patients more transparent cost estimates, leading to increased patient satisfaction.
- Health Tech
- Health tech startups can collaborate with cancer treatment centers and research institutes to develop innovative healthcare technologies that benefit patients and providers alike.
